FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.
- Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues. Universal health coverage: moving together to build a healthier world
- Joint Statement of Policy by FIP and the Global Self-Care Federation on Responsible and Effective Self-care
The objective of this statement is to describe the united role and intention of the pharmacy profession and industry in delivering solutions to people to facilitate self-care and in engaging with stakeholders including governments to further develop self-care as a core pillar of sustainable healthcare systems.
- FIP's “WHO technical guidelines: Points to consider in the provision by health-care professionals of children-specific preparations that are not available as authorized products (2016)
- Ethical principles of health care in times of armed conflict and other emergencies (2015)
Within the framework of the Health Care in Danger project, the World Medical Association (WMA), theInternational Committee of Military Medicine (ICMM), the International Council of Nurses (ICN) andthe International Pharmaceutical Federation (FIP) were consulted by the ICRC with the aim of theseorganizations agreeing on a common denominator of ethical principles of health care applicable intimes of armed conflict and other emergencies. The following document, which is the result of theseconsultations, is without prejudice to existing policy documents adopted by these organizations.
- Good Pharmacy Practice - Standards for Quality Services (2011, Hyderabad)
The International Pharmaceutical Federation (FIP) first adopted the guidelines for Good Pharmaceutical Practice in 1993. These guidelines were developed as a reference to be used by national pharmaceutical organisations, governments, and international pharmaceutical organizations to set up nationally accepted standards of Good Pharmacy Practice.
A revised version of this document was endorsed by WHO in 1997 and subsequently approved by the FIP Council in 1997.
In 2011, FIP and WHO adopted an updated version of Good Pharmacy Practice entitled "Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services".
In this document, the aim of pharmacy practice aim is defined as to "contribute to health improvement and to help patients with health problems to make the best use of their medicines."
GPP is defined as "the practice of pharmacy that responds to the needs of the people who use the pharmacists’ services to provide optimal, evidence-based care. To support this practice it is essential that there be an established national framework of quality standards and guidelines."
The 2011 GPP document underlines the requirements of Good Pharmacy Practice and how to set standards required for GPP, (which also imply a quality management framework and a strategic plan for developing services).
- The role of Pharmacists in Tuberculosis Care and Control (2011, Hyderabad)
- Ensuring Quality and Safety of Medicinal Products to Protect the Patient (1999, Barcelona)
- Responsible Self-medication
Adopted by FIP Council at its meeting in The Hague in September 1998 and signed by FIP and the World Self-Medication Industry (WSMI) in June 1999, this significant joint Declaration by FIP and WSMI provides guidance to pharmacists, patients and the industry regarding the safe and effective use of non-prescription medicines.
- Responsible Self-Medication (1998, The Hague)
- WHO/FIP Joint Declaration on the Role of the Pharmacist in the Fight Against the HIV-AIDS Pandemic (1997, Vancouver)
Impact of COVID-19 on Pharmacy Education: Perspective from students & academics
Due to the COVID-19 pandemic, there has been a change in the educational system where many universities are closed. The ways of learning for the student has changed from face to face to online, no education and/or remote education. This webinar aims to explore the impact of this lockdown from academic pharmacists and students’ perspectives. The structure of this webinar is an interactive discussion where the participants can share their thought and opinion. At the end of the webinar, some strategies to tackle these challenges would be discussed including managing mental health and wellbeing during self-isolation
- To describe an overview of education changes due to COVID-19;
- To identify challenges of remote education from the undergraduate and postgraduate students’ perspective;
- To discuss plans on tackling the challenges.